About the Joint Action
The general obective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
07 Dec 2021
Second iPAAC Local Stakeholder Forum in Lithuania
The second Lithuanian Local Stakeholder Forum will be held on 10 December 2021.
30 Nov 2021
Local Stakeholder Forum in Slovakia
The Slovak Local Stakeholder Forum was held in virtual settings on 22 November 2021.
19 Nov 2021
The contribution of iPAAC JA to building capacity for cancer prevention: WP5 webinar
The webinar brings an opportunity to take a look at opportunities and challenges of cancer prevention, based on the findings of the iPAAC Joint Action report and meetings.
18 Nov 2021
Local Stakeholder Forum in Poland
Polish Local Stakeholder Meeting (Hybrid Formula Conference with translation) will be held on 9 December 2021 during the Warsaw Summit of European Cancer Strategies.
10 Nov 2021
Example of the use of the iPAAC Roadmap: the French case study on the development of recommendations for the management of cognitive sequelae after cancer treatment
The French National Cancer Institute and Sciensano are pleased to invite you to an event that will present you an example of the use of the final iPAAC roadmap in the field of cognitive sequelae of cancer treatments.
10 Nov 2021
Genomics and cancer: from iPAAC to Europe’s Beating Cancer Plan
We are pleased to invite you to our Stakeholder Forum – Symposium on “Genomics and cancer: from iPAAC to Europe’s Beating Cancer Plan”.
03 Nov 2021
The iPAAC WP 9 Innovative Therapies in Cancer Final Workshop
The French National Cancer Institute (INCa) is pleased to invite you to the final workshop of the Work Package 9 dedicated to innovative therapies in cancer. This workshop will present the main results of this WP, which is a part of the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action.
18 Oct 2021
Local Stakeholder Forum in Italy
Italian Local Stakeholder Forum was held on 13 October 2021 in virtual settings.